Trials / Terminated
TerminatedNCT01902602
Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Herrmann Apparatebau GmbH · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments . In addition, data are collected on the immune system as well as for food and sleep quality.
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-03-01
- Completion
- 2016-06-01
- First posted
- 2013-07-18
- Last updated
- 2020-03-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01902602. Inclusion in this directory is not an endorsement.